Simplify Logo

Full-Time

Senior Director / Executive Director

Safety Assessment

Confirmed live in the last 24 hours

Altos Labs

Altos Labs

201-500 employees

Biotechnology focused on cell rejuvenation research

Hardware
Biotechnology

Compensation Overview

$324.7k - $483kAnnually

Expert

San Carlos, CA, USA + 1 more

UK Citizenship Required

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in Toxicology, Pharmacology or related sciences (or DVM) and a minimum of 15-20+ years of industry experience in Pathology/Toxicology
  • Deep expertise in Drug Development, with a proven track record of working in cross functional teams to bring drugs from Discovery to Clinic
  • Track record of regulatory filings and participation in regulatory interactions
  • Strong scientific aptitude and ability to implement investigative strategies to elucidate mechanisms of toxicity; expertise in Discovery Toxicology, including small molecule lead optimization
  • Demonstrated ability to build, manage and lead groups responsible for supporting Toxicology deliverables in a team setting
  • Demonstrated understanding and established level of expertise employing preclinical models
  • Strong knowledge and agility in study design and data interpretation and in the integration of Toxicology studies in the drug progression paradigm, as well as in the incorporation of safety endpoints in pharmacology studies
  • 3Rs-centered, welfare-oriented approach to animal-based research
  • A critical thinker with the ability to analyze possibilities and solutions and make pragmatic trade-off
  • Clear and influential communicator: exceptional influencing skills that demonstrate strong thought partnership and create effective relationships with internal and external groups and individuals
Responsibilities
  • Develop and implement Toxicology strategies and build infrastructure to support discovery and development programs using internal resources and CROs
  • Recruit scientists and Director level leaders to build and manage a team to support Toxicology strategy across the three Altos sites (Toxicology, Discovery and Toxicological Pathology, Nonclinical Operations), to ensure delivery of high quality data packages in support of target validation through to regulatory filings
  • Conduct target safety assessments for early therapeutic targets, and work closely with laboratories in the Institutes of Science to understand and derisk the safety of targets early on
  • Plan and execute in vitro safety screens to lead optimize small molecules, ASOs and gene therapy vectors
  • Work closely with CROs to coordinate and manage external toxicology studies
  • Represent Toxicology in multifunctional discovery and early development project teams
  • Effective cross-functional collaboration, especially with Institutes of Science, In Vivo Pharmacology and DMPK, in the optimization of drug leads and candidates
  • Contribute to the cross-functional review of regulatory documents and author and review Toxicology sections for relevant regulatory documents
  • Recommend, initiate, lead and champion new innovations to ensure relevant cutting-edge science is applied to project related issues
  • Create and foster strong partnerships with groups at the Institutes of Science
  • Contributes to a team culture that promotes continuous improvement, ownership, professional growth, and inclusion

Altos Labs specializes in biotechnology with a focus on cell rejuvenation, aiming to restore cell health and resilience to reverse diseases and injuries. Their approach involves cellular rejuvenation programming, which enhances cells' ability to resist stressors that can lead to illness. Unlike competitors, Altos Labs emphasizes collaboration with research institutions and healthcare providers to advance their scientific research. The company's goal is to improve patients' quality of life by developing effective treatments through cell rejuvenation.

Company Stage

Series A

Total Funding

$6.3B

Headquarters

Los Altos, California

Founded

2021

Growth & Insights
Headcount

6 month growth

2%

1 year growth

8%

2 year growth

81%
Simplify Jobs

Simplify's Take

What believers are saying

  • Altos Labs' pioneering work in cell rejuvenation could lead to revolutionary treatments that significantly improve quality of life and longevity.
  • The company's strong financial backing and high-profile leadership offer stability and growth potential for employees.
  • Collaborations with leading research institutions and healthcare providers can open up numerous opportunities for professional development and innovation.

What critics are saying

  • The highly experimental nature of cellular rejuvenation means that successful commercialization is uncertain and could take years.
  • High expectations from investors and the public could lead to pressure and stress for employees.

What makes Altos Labs unique

  • Altos Labs focuses on cellular rejuvenation, a niche yet groundbreaking area in biotechnology, setting it apart from traditional biotech firms.
  • The involvement of Nobel laureates like Jennifer Doudna in their board of directors adds unparalleled scientific credibility and expertise.
  • Significant funding from high-profile investors like Jeff Bezos provides a robust financial foundation for extensive R&D.